USPTO serial 79327653
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brian M. Davis
Brian M. Davis VLP Law Group LLP5960 Fairview Rd; Suite 400Charlotte, NC 28210UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Pharmaceuticals, medical and veterinary preparations for use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; pharmaceutical, medical and veterinary preparations for prevention, diagnosis and treatment of skin diseases; pharmaceutical, medical and veterinary preparations for dermatitis; pharmaceutical, medical and veterinary preparations for inflammatory diseases; medicines for veterinary purposes for use in the treatment of cancer, skin disorders and inflammatory diseases; pharmaceutical, medical and ] veterinary preparations containing alpha interferon for the prevention, diagnosis and treatment of diseases and disorders, namely, cancer, dermatitis, skin diseases, * pruritic conditions, coronavirus and allergies * [ and inflammatory diseases; pharmaceutical, medical and veterinary preparations containing alpha interferon for the prevention, diagnosis and treatment of diseases and disorders, namely, cancer, dermatitis, skin diseases and inflammatory diseases, for animals; pharmaceutical, medical and veterinary drugs for use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biological preparations for medical use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; biological reagents being pharmaceutical preparations for medical use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; biological tissue cultures for medical use; biochemical preparations for medical use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; anti-viral agents; diagnostic preparations for medical and veterinary purposes; clinical diagnostic reagents for medical and veterinary purposes; immunoassay reagents for medical use ] | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 21, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 13, 2025 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| May 1, 2025 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Apr 24, 2025 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Apr 24, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 11, 2024 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| May 30, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 5, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 5, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 30, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 31, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 31, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 13, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 15, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 15, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 26, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 11, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 4, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 3, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 3, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 19, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 24, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 24, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 22, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 21, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 21, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 14, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 10, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 9, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |